Condition: Diabetes · Diabetic Retinopathy · Type 2 Diabetes Mellitus (T2DM) · Sponsor: Yufan Wang
This study aims to integrate clinical indicators and features of fundus images, combined with metabolomics, to construct an early warning model for diabetic retinopathy (DR) in type 2 diabetes. By combining clinical indicators with metabolomics, the investigators aim to establish a precise DR typing model based on the age of diabetes onset (early-onset diabetes, late-onset diabetes) and based on the coexistence with two types of diabetic macrovascular complications. A multidisciplinary collaboration will be conducted for comprehensive management of DR to control the progression of moderate-stage DR. Cloud-based patient rooms combined with continuous glucose monitoring (CGM) will further explore the role of integrated diabetes retinopathy ward management models in the management of patients undergoing diabetes retinopathy surgery, pioneering a new model for the management of advanced DR.
This description comes directly from the study's public registry record.
Liping Gu Liping Gu · 86-13564720656 · guliping1980@126.com
Always discuss trial participation with your own doctor first.
| The first hosptial of lanzhou university | Lanzhou, China | Recruiting |
| Shanghai general hosptial | Shanghai, China | Recruiting |
| The forth people's hosptial of shenyang | Shenyang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06821399